Bristol Myers Squibb Co
CELG.RI- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000014272
In the last 90 days, Bristol Myers Squibb Co insiders filed 0 open-market purchases and 2 sales; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Other share classesBMY
Holders of 5% or more of CELG.RI
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Bristol Myers Squibb Co, largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Bristol Myers Squibb Co on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on Bristol Myers Squibb Co, newest first.
No Schedule 13D or 13G filings on Bristol Myers Squibb Co are on file.
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Bristol Myers Squibb Co shares.
No Form 144 notices for Bristol Myers Squibb Co are on file.